We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

C4X Discovery Holdings plc (C4XD) Ordinary Shares 1p

Sell:21.40p Buy:22.40p 0 Change: 0.1p (0.47%)
Market closed Prices as at close on 6 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:21.40p
Buy:22.40p
Change: 0.1p (0.47%)
Market closed Prices as at close on 6 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:21.40p
Buy:22.40p
Change: 0.1p (0.47%)
Market closed Prices as at close on 6 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

C4X Discovery Holdings PLC is a United Kingdom-based company, which is engaged in the research and development through the identification, assessment and validation of Drug Discovery targets. The Company operates by early commercial partnering or initiation of a its drug discovery program to develop a small molecule. The Company also works in collaboration with partners. The Company has a portfolio ranging from early stage-target to late-stage drug discovery program ready for out-licensing to partners. The Company’s portfolio of pre-clinical small molecule candidates includes Oral NRF2 activator, Oral MALT1 inhibitor, Oral α4β7 integrin inhibitor, Oral Orexin-1 Antagonist (C4X_3256/INDV-2000), Oral IL-17A Inhibitor. It has developed activators of the NRF2 pathway for the treatment of a variety of inflammatory diseases including Inflammatory Bowel Disease (IBD), Sickle Cell Disease (SCD), Pulmonary Arterial Hypertension (PAH) and Chronic Obstructive Pulmonary Disorder (COPD).

Contact details

Address:
Manchester One, 53 Portland Street
MANCHESTER
M1 3LD
United Kingdom
Telephone:
+44 (0161) 2355085
Website:
https://www.c4xdiscovery.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 28 April 2022 28/04/22
AGM 18 January 2022 18/01/22
Final results 13 December 2021 13/12/21

General stock information

EPIC:
C4XD
ISIN:
GB00BQQ2RV18
Market cap:
£48.14 million
Shares in issue:
229.23 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.